Evolving Role for Pharmacotherapy in NAFLD/NASH

• Hoofdauteurs: Suzanna L. Attia (Auteur), Samir Softic (Auteur), Marialena Mouzaki (Auteur)
• Formaat: Boek
• Gepubliceerd in: Wiley, 2021-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent, dynamic disease that occurs across the age spectrum and can lead to cirrhosis and hepatocellular carcinoma. There are currently no US Food and Drug Administration (FDA) approved treatments for NAFLD; however, this is a field of active r...